Your browser doesn't support javascript.
loading
Response to the letter: "Predictive factors for transition to conversion therapy in HCC using atezolizumab plus bevacizumab".
Kikuchi, Tatsuya; Takeuchi, Yasuto; Nouso, Kazuhiro; Kariyama, Kazuya; Kuwaki, Kenji; Toshimori, Junichi; Iwado, Shota; Moriya, Akio; Hagihara, Hiroaki; Takabatake, Hiroyuki; Tada, Toshifumi; Yasunaka, Tetsuya; Sakata, Masahiro; Sue, Masahiko; Miyake, Nozomi; Adachi, Takuya; Wada, Nozomu; Onishi, Hideki; Shiraha, Hidenori; Takaki, Akinobu; Otsuka, Motoyuki.
Afiliação
  • Kikuchi T; Department of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Japan.
  • Takeuchi Y; Department of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Japan.
  • Nouso K; Department of Regenerative Medicine, Center for Innovative Clinical Medicine, Okayama University Hospital, Okayama, Japan.
  • Kariyama K; Department of Gastroenterology, Okayama City Hospital, Okayama, Japan.
  • Kuwaki K; Department of Gastroenterology, Okayama City Hospital, Okayama, Japan.
  • Toshimori J; Department of Gastroenterology, Okayama Saiseikai General Hospital, Okayama, Japan.
  • Iwado S; Department of Gastroenterology, Japanese Red Cross Okayama Hospital, Okayama, Japan.
  • Moriya A; Department of Gastroenterology, Hiroshima City Hospital, Hiroshima, Japan.
  • Hagihara H; Department of Gastroenterology, Mitoyo General Hospital, Kanonji, Japan.
  • Takabatake H; Department of Gastroenterology, Sumitomo Besshi Hospital, Niihama, Japan.
  • Tada T; Department of Gastroenterology, Kurashiki Central Hospital, Kurashiki, Japan.
  • Yasunaka T; Department of Gastroenterology, Japanese Red Cross Himeji Hospital, Himeji, Japan.
  • Sakata M; Department of Gastroenterology, Fukuyama City Hospital, Fukuyama, Japan.
  • Sue M; Department of Gastroenterology, Fukuyama Medical Center, Fukuyama, Japan.
  • Miyake N; Department of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Japan.
  • Adachi T; Department of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Japan.
  • Wada N; Department of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Japan.
  • Onishi H; Department of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Japan.
  • Shiraha H; Department of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Japan.
  • Takaki A; Department of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Japan.
  • Otsuka M; Department of Gastroenterology and Hepatology, Okayama University Hospital, Okayama, Japan.
Liver Int ; 44(7): 1736-1737, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38717049
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Hepatocelular / Anticorpos Monoclonais Humanizados / Bevacizumab / Neoplasias Hepáticas Limite: Humans Idioma: En Revista: Liver Int Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Hepatocelular / Anticorpos Monoclonais Humanizados / Bevacizumab / Neoplasias Hepáticas Limite: Humans Idioma: En Revista: Liver Int Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Japão